Betamethasone Dosing Interval - 12 or 24 Hours?
NCT00453141 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2009-11-10
Summary
The purpose of this study is to determine if there may be a benefit to the newborn if betamethasone is given 12 hours apart instead of 24 hours apart.
Conditions
- Preterm Delivery
Interventions
- DRUG
-
dosing of Betamethasone
Sponsors & Collaborators
-
The Cooper Health System
lead OTHER
Principal Investigators
-
Meena Khandelwal, MD · The Cooper Health System
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetics, -Dynamics and Safety of Intravenous Paracetamol in Neonates
NCT00969176 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels
NCT03097484 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Heparin on the Need for Mechanical Ventilation in Neonates
NCT00196469 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Prevalence of Complications Occurring in the Mother-newborn Couple During the First Month After Returning Home, Since the Introduction of Standard Outpatients (According to HAS 2014 Recommendations) at the Amiens-Picardie University Hospital
NCT03114930 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal Intensive Care
NCT05371886 ·Status: RECRUITING ·Phase: NA
-
Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation
NCT02040909 ·Status: TERMINATED ·Phase: PHASE1
-
New Procedure to Reduce Mother-newborn Separation
NCT06594458 ·Status: RECRUITING ·Phase: NA
-
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
NCT04772222 ·Status: COMPLETED ·Phase: PHASE2
-
Atropine Versus no Atropine for Neonatal Rapid Sequence Intubation
NCT01595399 ·Status: UNKNOWN ·Phase: PHASE4
-
Thyroid Function in Term Infants With Respiratory Distress
NCT00293956 ·Status: COMPLETED
-
The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome
NCT01754324 ·Status: COMPLETED
-
Methadone Pharmacokinetics and Cardiac Effects in Newborns
NCT00715988 ·Status: COMPLETED ·Phase: PHASE1
-
Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome
NCT03762317 ·Status: TERMINATED ·Phase: PHASE4
-
Intrapartum Epidural Fentanyl/Bupivacaine Analgesia, Infant Feeding Behavior, & Breast-Feeding Outcomes
NCT01260051 ·Status: COMPLETED
-
Clonidine for Neonatal Abstinence Syndrome Study
NCT01175668 ·Status: TERMINATED ·Phase: NA
-
Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants
NCT01819064 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatitis B Vaccination After Neonatal Surgery
NCT06023056 ·Status: RECRUITING
-
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
NCT04298853 ·Status: COMPLETED ·Phase: PHASE4
-
Hypothermia's Effect on Hepatitis B Vaccination
NCT05787899 ·Status: COMPLETED
-
Extremely Low Gestatonal Age Infants' Paracetamol Study
NCT03641209 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Early Use of Caffeine Citrate in Preterm Neonates
NCT04001712 ·Status: COMPLETED ·Phase: PHASE3
-
NAS Treatment - Opiate Versus Non-Opiate
NCT01734551 ·Status: COMPLETED ·Phase: PHASE4
-
Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome
NCT00391105 ·Status: COMPLETED ·Phase: PHASE4
-
Safe Excipient Exposure in Neonates and Small ChildreN
NCT02545712 ·Status: UNKNOWN
-
Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates
NCT06318637 ·Status: COMPLETED ·Phase: NA